https://www.selleckchem.com/products/680c91.html
Although exhaustive efforts to prevent and treat tuberculosis (T was taken the problem still continues due to multi-drug-resistant (MDR) and extensively drug resistant TB (XDR-T. It clearly highlights the urgent need to develop novel "druggable" molecules for the co-infection treatment and strains of MDR-TB and XDR-TB. In this approach a hybrid molecule was created by merging two or more pharmacophores. Active site of targets may be addressed by each of the pharmacophores and proffers the opportunity for selectivity. In addition, it
Like
Comment
Share
